BOSCHI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 12.291
AS - Asia 7.701
EU - Europa 4.874
SA - Sud America 1.326
AF - Africa 192
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.430
Nazione #
US - Stati Uniti d'America 11.966
SG - Singapore 2.933
CN - Cina 1.839
IT - Italia 1.274
BR - Brasile 1.041
VN - Vietnam 962
PL - Polonia 669
DE - Germania 648
HK - Hong Kong 619
GB - Regno Unito 484
UA - Ucraina 460
TR - Turchia 314
FI - Finlandia 301
JP - Giappone 242
FR - Francia 239
IN - India 181
SE - Svezia 177
RU - Federazione Russa 166
CA - Canada 150
MX - Messico 136
ID - Indonesia 128
AR - Argentina 103
BD - Bangladesh 98
NL - Olanda 94
ZA - Sudafrica 83
ES - Italia 59
IQ - Iraq 59
BE - Belgio 52
AT - Austria 51
EC - Ecuador 43
UZ - Uzbekistan 42
AU - Australia 41
VE - Venezuela 40
PK - Pakistan 38
CH - Svizzera 35
CO - Colombia 35
IR - Iran 27
CZ - Repubblica Ceca 26
MY - Malesia 26
PH - Filippine 26
LT - Lituania 24
MA - Marocco 23
BG - Bulgaria 21
CL - Cile 21
SA - Arabia Saudita 20
TN - Tunisia 19
HU - Ungheria 15
JO - Giordania 15
KE - Kenya 15
TW - Taiwan 14
AZ - Azerbaigian 13
BO - Bolivia 13
DK - Danimarca 13
AE - Emirati Arabi Uniti 12
KR - Corea 11
PT - Portogallo 11
DZ - Algeria 10
EG - Egitto 10
NP - Nepal 10
PY - Paraguay 10
IE - Irlanda 9
IL - Israele 9
UY - Uruguay 9
KG - Kirghizistan 8
LB - Libano 8
RO - Romania 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
CR - Costa Rica 6
ET - Etiopia 6
JM - Giamaica 6
KZ - Kazakistan 6
LV - Lettonia 6
BY - Bielorussia 5
HN - Honduras 5
NO - Norvegia 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
GY - Guiana 4
AL - Albania 3
BB - Barbados 3
CG - Congo 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
MK - Macedonia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
EU - Europa 2
GT - Guatemala 2
KH - Cambogia 2
Totale 26.388
Città #
Singapore 1.865
Ashburn 1.420
San Jose 908
Woodbridge 845
Fairfield 783
Warsaw 657
Hong Kong 606
Beijing 581
Chandler 572
Santa Clara 563
Houston 549
Ann Arbor 511
Jacksonville 485
Ferrara 330
Wilmington 303
Ho Chi Minh City 292
Seattle 279
Los Angeles 245
Tokyo 228
Cambridge 225
Hanoi 213
The Dalles 212
New York 192
Nanjing 191
Dallas 190
Munich 184
Izmir 179
Addison 159
Lauterbourg 144
Princeton 144
Milan 127
Helsinki 125
São Paulo 118
Council Bluffs 117
Boardman 101
Shanghai 88
Buffalo 82
Dearborn 82
Dong Ket 81
Mexico City 80
Jakarta 78
London 71
Orem 71
Turku 71
San Diego 65
Redwood City 57
Bologna 56
Montreal 56
Da Nang 53
Nuremberg 53
Chennai 49
Bremen 48
Brooklyn 48
Tianjin 46
Frankfurt am Main 45
Nanchang 44
Rome 44
Brussels 43
Denver 42
Johannesburg 41
Shenyang 41
Chicago 40
Boston 39
Hefei 37
Stockholm 37
Tashkent 36
Phoenix 35
Toronto 35
Poplar 32
Vienna 32
Amsterdam 31
Atlanta 31
Changsha 30
Haiphong 30
Hebei 30
Moscow 30
Rio de Janeiro 30
San Francisco 28
Guangzhou 26
Baghdad 24
Falls Church 24
Legnaro 24
Padova 23
Biên Hòa 22
Jiaxing 22
Kunming 22
Zurich 22
Augusta 21
Chengdu 21
Mumbai 21
L’Aquila 20
Belo Horizonte 19
Ankara 18
Brasília 18
Dhaka 18
Charlotte 17
Lahore 17
Monmouth Junction 17
Ningbo 17
Auburn Hills 16
Totale 17.190
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 511
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 385
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 334
Biodistribution of nanostructured lipid carriers: a tomographic study 325
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 316
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 315
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 287
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 285
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 284
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 277
A solvent-extraction module for cyclotron production of high-purity technetium-99m 270
LARAMED: A Laboratory for Radioisotopes of Medical Interest 269
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 266
YAP-(S)PET small animal scanner: Quantitative results 250
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 248
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 239
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 233
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 231
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 230
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 222
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 220
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 219
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 218
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 218
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 214
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 213
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 211
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 210
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 209
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 206
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 204
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 203
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 196
Extraction techniques of 99mTc from 100Mo Metal Target 195
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 195
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 194
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 192
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 190
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 189
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 189
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 187
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 185
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 184
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 184
Development of a β-spectrometer for 99gTc Activity Estimations 183
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 179
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 177
188W/188Re generator system and its therapeutic applicacions 176
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 175
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 175
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 174
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 171
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 171
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 170
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 170
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 169
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 169
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 168
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 168
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 168
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 165
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 165
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 164
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 164
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 162
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 160
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 158
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 158
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 157
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 154
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 153
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 153
Technetium complexes and radiopharmaceuticals with scorpionate ligands 153
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 153
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 152
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 151
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 148
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 147
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 146
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 145
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 145
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 143
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 143
Radioactive metal complexes comprising a tridentate complexing sequence 143
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 140
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 139
Advances in the automation technologies within LARAMED project 139
Production of 47Sc with natural vanadium targets: results of the PASTA project 138
First in vivo imaging studies of cyclotron produced 99mTc-HMPAO 138
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 136
PASTA Project: Data Analysis 136
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 135
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 135
Efficient preparation and stabilization of Re-188-MDP under physiological conditions 133
Perspectives on the use of liquid extraction for radioisotope purification 132
Cyclotron-Production of Mn-52: an update on the METRICS project 131
LABELLING OF SMALL MOLECULES WITH THE 99mTc-NITRIDO CORE (cap.15) 130
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 129
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 129
Recent Advances in Preclinical Studies of the Theranostic Agent [64Cu]CuCl2 129
Totale 19.196
Categoria #
all - tutte 112.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.795
Totale 124.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021708 0 0 0 0 0 0 0 0 0 305 244 159
2021/20221.597 71 118 103 75 66 67 83 92 73 125 245 479
2022/20231.419 163 135 42 173 207 189 95 109 130 25 93 58
2023/20241.046 73 94 99 46 69 125 75 73 33 41 51 267
2024/20254.546 120 111 333 182 462 306 196 268 680 555 893 440
2025/202610.927 1.076 436 930 1.467 1.753 807 1.478 753 1.131 1.096 0 0
Totale 26.823